Michael Nicholson

N-Viro International Corp. is a technology, service, and process handling company, which engages in conversion process of bioorganic materials. It integrates technology with its alternative energy product, N-Viro Fuel for commercial applications. The company also owns and licenses various N-Viro processes and patented technologies to treat and recycle wastewater and other bio-organic wastes, utilizing certain alkaline and mineral by-products produced by the cement, lime, electrical generation and other industries. N-Viro International was founded in April 1993 and is headquartered in Toledo, OH.

Inceptor Bio LLC operates as a biotechnology industry company. The company is headquartered in Raleigh, NC.

Specific Biologics, Inc. is a biotechnology company that focuses on developing gene editing technologies to treat diseases through precision gene editing. The company is based in Toronto, Canada. The Canadian company's two-site dualase™ platform gene editors cut DNA in a way that optimally exploits the cells naturally occurring DNA repair pathways, enabling two gene editing outcomes, precise DNA deletions to disrupt genes or increased repair to correct genes. Specific also develops lipid nanoparticles to deliver the gene editor to target cells and is developing a pipeline of dualase™-based therapeutics in areas of high unmet medical need. The company was founded in 2017. The CEO is Brent Stead.